National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

For the treatment of adult patients with Cushing’s Disease for whom surgery is not an option or for whom surgery has failed

Rapid Review

Commenced Completed Outcome
29/03/2012 10/04/2012 Full Pharmacoeconomic Evaluation Recommended

The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.